Biotech startup funding holds steady amid AI surge
Even as startup investment set new records—driven by generative AI—biotech funding has stayed steady, sticking between $36 and $40 billion globally for several years. AI-focused biotechs raised a notable $6 billion so far this year, with London’s Isomorphic Labs landing the largest biotech round at $2.1 billion. Most biotech funding still goes to early-stage startups, and several, like Kailera Therapeutics, have gone public early.
- Global biotech funding stuck near $36–40 billion yearly
- AI-focused biotechs raised over $6 billion this year
- Isomorphic Labs led with $2.1 billion Series B
- Early-stage biotech rounds make up most of the total
- Some biotechs now go public soon after early funding
Sources covering this
More in Startups
Félix raises $200M for WhatsApp remittance tool
Félix, which lets Latino immigrants send money home via WhatsApp, just raised $200 million in Series C funding. Andreessen Horowitz put in $87 million of equity; General Catalyst gave $113 million in growth debt. The Miami startup says it’s handled over $8 billion in payments so far, serving U.S. users with families in 11 Latin American countries. Félix plans to expand into new markets with the cash.
Venture-backed startup IPOs surge past $110 billion in 2026
So far in 2026, private startups have raised $110.8 billion from IPOs—almost nine times last year’s haul for the same stretch, thanks mostly to SpaceX’s $86 billion debut in June. Crunchbase flags more to watch before year-end, including Anthropic, which could go public as soon as September or October and reportedly may raise up to $100 billion if it does.
Nua raises $50 million for women's wellness products
Nua, a Mumbai-based startup making wellness products for women, just raised $50 million in Series C funding. Peak XV Partners and Filter Capital led the round. Nua says they've grown their yearly revenue fivefold in two years, hitting about ₹500 crore, and stayed profitable. The new money will go to expanding their product range, boosting distribution, and investing in R&D. Several early investors took partial exits.
Sugar Cosmetics gets $15 million, valuation drops 80%
Sugar Cosmetics just raised about ₹145 crore (around $15 million) from its existing backer, A91 Partners, but what's catching eyes is the new price tag. The company's valuation now stands at roughly ₹550-600 crore—down 75-80% from the nearly ₹3,000 crore it was worth at its peak in 2022. This comes after Sugar's revenue dropped and losses widened last year.